Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673355 | SCV000798545 | uncertain significance | Ellis-van Creveld syndrome | 2018-03-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002493115 | SCV002784743 | uncertain significance | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2021-10-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002493115 | SCV003520034 | uncertain significance | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2022-03-29 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 295 of the EVC protein (p.Thr295Ser). This variant is present in population databases (rs754532508, gnomAD 0.08%). This missense change has been observed in individual(s) with Ellis-van Creveld syndrome (PMID: 28253570). ClinVar contains an entry for this variant (Variation ID: 557239). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |